Mepolizumab for Severe Refractory Eosinophilic Asthma: Evidence to Date and Clinical Potential
Therapeutic Advances in Chronic Disease - United States
doi 10.1177/2040622316659863
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 20, 2016
Authors
Publisher
SAGE Publications